Gail Frances McIntyre is President & VP at Furiex Pharmaceuticals, Inc. (FURX). They have made 5 open-market trades across 2 companies since 2011, most recently 2022-10-24.
CIK 0001492646
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $161K since 2011, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARAV | BUY | 2021-06-29 | 2021-06-29 | $5.35 | $5K | -5.2% | -23.2% | -22.8% |
| ARAV | BUY | 2020-12-04 | 2020-12-07 | $5.77 | $46K | +4.7% | -10.1% | +13.7% |
| FURX | SELL | 2014-06-16 | 2014-06-18 | $105.01 | $7.8M | N/A | N/A | N/A |
| FURX | SELL | 2014-06-10 | 2014-06-12 | $104.58 | $183K | N/A | N/A | N/A |
| FURX | SELL · 10b5-1 | 2013-07-19 | 2013-07-23 | $40.00 | $423K | N/A | N/A | N/A |
| FURX | SELL · 10b5-1 | 2013-07-19 | 2013-09-18 | $40.00 | $800K | N/A | N/A | N/A |
| FURX | BUY | 2011-11-17 | 2011-11-21 | $16.89 | $110K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.